Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS).
Journal Information
Full Title: Curr Atheroscler Rep
Abbreviation: Curr Atheroscler Rep
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Vascular Diseases
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of Interest Laura D’Erasmo has received personal fees for public speaking, consultancy, or grant support from Amryt Pharmaceuticals, Akcea Therapeutics, Pfizer, Amgen, and Sanofi. Marcello Arca has received research grant support from Amryt Pharmaceutical, Amgen, IONIS, Akcea Therapeutics, Pfizer, and Sanofi; has served as a consultant for Amgen, Aegerion, Akcea Therapeutics, Regeneron, Sanofi, and Alfasigma; and received lecturing fees from Amgen, Amryt Pharmaceutical, Pfizer, Sanofi, and AlfaSigma. Simone Bini declares no competing interests."
"Funding Open access funding provided by Università degli Studi di Roma La Sapienza within the CRUI-CARE Agreement."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025